Polypharmacy in older adults
Pro Research Analysisby 
Searched over 200M research papers
Definitions and Prevalence of Polypharmacy in Older Adults
Polypharmacy, commonly defined as the use of five or more medications, is a widespread and growing issue among older adults, especially those with multiple chronic conditions Pazan2021Wastesson2018Midão2018+3 MORE. However, there is no universally accepted definition, with over 140 different definitions identified in the literature, most of which are based on medication count Pazan2021Wastesson2018Davies2020+1 MORE. The prevalence of polypharmacy varies widely depending on the setting and definition used, ranging from as low as 4% in community-dwelling older adults to over 96% in hospitalized patients Pazan2021Midão2018Hsu2020. In European community settings, prevalence rates typically range from 26% to 40% , while in nursing homes and hospitals, rates are much higher Pazan2021Maher2014.
Factors Associated with Polypharmacy in the Elderly
Several factors increase the likelihood of polypharmacy in older adults, including advanced age, multiple chronic diseases, physical inactivity, depression, poor self-perceived health, limitations in daily activities, and lower quality of life Midão2018Hsu2020. Socioeconomic factors such as lower education and financial difficulties also play a role . Cardiovascular drugs are the most commonly used medications among older adults with polypharmacy .
Adverse Clinical Consequences and Risks
Polypharmacy in older adults is strongly linked to a range of negative health outcomes. These include increased risk of adverse drug reactions, drug-drug interactions, medication nonadherence, falls, hospitalizations, disability, and higher mortality rates Pazan2021Wastesson2018Midão2018+4 MORE. Meta-analyses show that polypharmacy is associated with a 28% higher risk of death and a 50% higher risk of hospitalization, with even greater risks for those taking ten or more medications . The risk of inappropriate prescribing and medication-related problems also rises with the number of medications used Maher2014Davies2020Hoel2021. However, the evidence for some adverse outcomes is conflicting, partly due to inconsistent definitions and confounding by multimorbidity Wastesson2018Davies2020Mehta2021.
Approaches to Polypharmacy Management and Deprescribing
Managing polypharmacy in older adults requires systematic approaches to identify and reduce unnecessary or high-risk medications Hoel2021Mehta2021Kurczewska-Michalak2021. The most effective interventions involve regular medication reviews using explicit criteria such as the STOPP/START or Beers criteria, often supported by computerized decision support systems Hoel2021Kurczewska-Michalak2021. Interprofessional teams, including clinical pharmacists, are effective in reducing inappropriate prescribing, though the impact on long-term health outcomes is mixed Maher2014Hoel2021Kurczewska-Michalak2021. Deprescribing—systematically reducing or stopping medications that may no longer be necessary—should be tailored to the patient’s health status and care goals, especially in palliative or long-term care settings Hoel2021Mehta2021Kurczewska-Michalak2021.
Challenges and Future Directions
The lack of a standardized, clinically relevant definition of polypharmacy complicates research and management efforts Pazan2021Wastesson2018Davies2020+1 MORE. Future research should focus on developing better definitions and risk stratification tools, as well as understanding the social consequences of polypharmacy, such as loneliness and isolation Davies2020Mehta2021. There is also a need for more longitudinal studies to track how polypharmacy develops and to evaluate the effectiveness of interventions over time Hsu2020Mehta2021Kurczewska-Michalak2021.
Conclusion
Polypharmacy is highly prevalent among older adults and is associated with significant health risks, including increased mortality, hospitalizations, and adverse drug events. Effective management requires regular medication reviews, interprofessional collaboration, and patient-centered deprescribing strategies. Standardizing definitions and improving research methods will be crucial for advancing care and reducing the harms of polypharmacy in the aging population.
Sources and full results
Most relevant research papers on this topic